Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2008 1
2011 3
2012 5
2013 2
2014 1
2015 2
2016 3
2017 2
2018 2
2019 1
2020 1
2021 6
2022 5
2023 2
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Le Pechoux C, et al. Among authors: pourel n. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Lancet Oncol. 2022. PMID: 34919827 Clinical Trial.
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results.
Levy A, Adebahr S, Hurkmans C, Ahmed M, Ahmad S, Guckenberger M, Geets X, Lievens Y, Lambrecht M, Pourel N, Lewitzki V, Konopa K, Franks K, Dziadziuszko R, McDonald F, Fortpied C, Clementel E, Fournier B, Rizzo S, Fink C, Riesterer O, Peulen H, Andratschke N, McWilliam A, Gkika E, Schimek-Jasch T, Grosu AL, Le Pechoux C, Faivre-Finn C, Nestle U. Levy A, et al. Among authors: pourel n. J Thorac Oncol. 2024 Sep;19(9):1297-1309. doi: 10.1016/j.jtho.2024.05.366. Epub 2024 May 22. J Thorac Oncol. 2024. PMID: 38788924 Clinical Trial.
Radiotherapy in the management of lung oligometastases.
Bourbonne V, Lévy A, Khalifa J, Antoni D, Blais E, Darréon J, Le Péchoux C, Lerouge D, Giraud P, Marguerit A, Pourel N, Riet FG, Thureau S. Bourbonne V, et al. Among authors: pourel n. Cancer Radiother. 2024 Feb;28(1):36-48. doi: 10.1016/j.canrad.2023.06.030. Epub 2024 Jan 16. Cancer Radiother. 2024. PMID: 38228422 Review.
[Informed consent in radiotherapy care].
Sire C, Ducteil A, Lagrange JL, Maingon P, Lorchel F, Latorzeff I, Hennequin C, Giraud P, Leroy T, Vendrely V, Hannoun-Lévi JM, Chargari C, Pourel N, Elhouat Y, Mazeron JJ, Marchesi V, Huguet F, Monpetit É, Azria D. Sire C, et al. Among authors: pourel n. Cancer Radiother. 2024 Jun;28(3):290-292. doi: 10.1016/j.canrad.2024.04.001. Epub 2024 Jun 11. Cancer Radiother. 2024. PMID: 38866651 French.
Radiotherapy for primary lung cancer.
Khalifa J, Lerouge D, Le Péchoux C, Pourel N, Darréon J, Mornex F, Giraud P. Khalifa J, et al. Among authors: pourel n. Cancer Radiother. 2022 Feb-Apr;26(1-2):231-243. doi: 10.1016/j.canrad.2021.11.005. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953709
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Péchoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P. Vera P, et al. Among authors: pourel n. Lancet Oncol. 2024 Sep;25(9):1176-1187. doi: 10.1016/S1470-2045(24)00320-6. Epub 2024 Aug 9. Lancet Oncol. 2024. PMID: 39134086 Clinical Trial.
[Radiotherapy for small cell lung carcinoma].
Pourel N. Pourel N. Cancer Radiother. 2016 Oct;20(6-7):547-57. doi: 10.1016/j.canrad.2016.07.092. Epub 2016 Sep 7. Cancer Radiother. 2016. PMID: 27614522 Review. French.
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus Initiative.
Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury JM, Bonte PE, Coutte A, Pourel N, Bourbonne V, Pradier O, Belliere A, Le Tinier F, Deberne M, Tanguy R, Denis F, Padovani L, Zaccariotto A, Molina T, Chalabreysse L, Brioude G, Delatour B, Faivre JC, Cao K, Giraud P, Riet FG, Thureau S, Antoni D, Massabeau C, Keller A, Bonnet E, Lerouge D, Martin E, Girard N, Botticella A. Basse C, et al. Among authors: pourel n. J Thorac Oncol. 2024 Jul;19(7):1095-1107. doi: 10.1016/j.jtho.2024.04.003. Epub 2024 Apr 10. J Thorac Oncol. 2024. PMID: 38608932
Radiotherapy in the management of synchronous metastatic lung cancer.
Khalifa J, Lévy A, Sauvage LM, Thureau S, Darréon J, Le Péchoux C, Lerouge D, Pourel N, Antoni D, Blais E, Martin É, Marguerit A, Giraud P, Riet FG. Khalifa J, et al. Among authors: pourel n. Cancer Radiother. 2024 Feb;28(1):22-35. doi: 10.1016/j.canrad.2023.03.002. Epub 2023 Aug 11. Cancer Radiother. 2024. PMID: 37574329 Review.
[Radiation-related heart toxicity].
Mège A, Ziouèche A, Pourel N, Chauvet B. Mège A, et al. Among authors: pourel n. Cancer Radiother. 2011 Oct;15(6-7):495-503. doi: 10.1016/j.canrad.2011.06.003. Epub 2011 Aug 31. Cancer Radiother. 2011. PMID: 21885320 Review. French.
38 results